AssetMark Inc’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.86K | Sell |
188
-522
| -74% | -$12K | ﹤0.01% | 2772 |
|
|
2026
Q1 | $15.6K | Buy |
710
+655
| +1,191% | +$11.4K | ﹤0.01% | 2146 |
|
|
2025
Q4 | $648 | Hold |
55
| – | – | ﹤0.01% | 3051 |
|
|
2025
Q3 | $871 | Hold |
55
| – | – | ﹤0.01% | 2812 |
|
|
2025
Q2 | $630 | Sell |
55
-35
| -39% | -$394 | ﹤0.01% | 2700 |
|
|
2025
Q1 | $1.22K | Sell |
90
-145
| -62% | -$2.41K | ﹤0.01% | 2266 |
|
|
2024
Q4 | $3.97K | Sell |
235
-381
| -62% | -$7.41K | ﹤0.01% | 1983 |
|
|
2024
Q3 | $12.5K | Buy |
616
+227
| +58% | +$4.64K | ﹤0.01% | 1593 |
|
|
2024
Q2 | $8.78K | Buy |
389
+3
| +0.8% | +$79 | ﹤0.01% | 1523 |
|
|
2024
Q1 | $10.1K | Sell |
386
-5
| -1% | -$142 | ﹤0.01% | 1377 |
|
|
2023
Q4 | $12.3K | Buy |
391
+5
| +1% | +$136 | ﹤0.01% | 1353 |
|
|
2023
Q3 | $10.8K | Hold |
386
| – | – | ﹤0.01% | 1324 |
|
|
2023
Q2 | $14.2K | Hold |
386
| – | – | ﹤0.01% | 1252 |
|
|
2023
Q1 | $11.6K | Hold |
386
| – | – | ﹤0.01% | 1257 |
|
|
2022
Q4 | $11.8K | Hold |
386
| – | – | ﹤0.01% | 1284 |
|
|
2022
Q3 | $10K | Hold |
386
| – | – | ﹤0.01% | 1223 |
|
|
2022
Q2 | $12K | Hold |
386
| – | – | ﹤0.01% | 1198 |
|
|
2022
Q1 | $12K | Hold |
386
| – | – | ﹤0.01% | 1162 |
|
|
2021
Q4 | $13K | Buy |
+386
| New | +$12K | ﹤0.01% | 1115 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | – | – | 1318 |
|
|
2020
Q2 | $0 | Buy |
+10
| New | +$126 | ﹤0.01% | 1277 |
|
|
2019
Q2 | – | Sell |
-1,333
| Closed | -$50K | – | 1342 |
|
|
2019
Q1 | $50K | Sell |
1,333
-9
| -0.7% | -$327 | ﹤0.01% | 698 |
|
|
2018
Q4 | $38K | Buy |
+1,342
| New | +$42.4K | ﹤0.01% | 743 |
|
|
2018
Q1 | – | Sell |
-47
| Closed | -$2K | – | 1489 |
|
|
2017
Q4 | $2K | Sell |
47
-59
| -56% | -$3.09K | ﹤0.01% | 1434 |
|
|
2017
Q3 | $5K | Sell |
106
-10
| -9% | -$472 | ﹤0.01% | 1141 |
|
|
2017
Q2 | $4K | Sell |
116
-9
| -7% | -$355 | ﹤0.01% | 1127 |
|
|
2017
Q1 | $5K | Buy |
125
+25
| +25% | +$752 | ﹤0.01% | 1030 |
|
|
2016
Q4 | $2K | Hold |
100
| – | – | ﹤0.01% | 1126 |
|
|
2016
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 1115 |
|
|
2016
Q2 | $1K | Sell |
100
-12
| -11% | -$107 | ﹤0.01% | 1117 |
|
|
2016
Q1 | $1K | Sell |
112
-55
| -33% | -$276 | ﹤0.01% | 1101 |
|
|
2015
Q4 | $1K | Sell |
167
-736
| -82% | -$4.7K | ﹤0.01% | 1179 |
|
|
2015
Q3 | $6K | Buy |
+903
| New | +$9.45K | ﹤0.01% | 532 |
|
Other funds holding CC
CCPM
AssetMark Inc's CC Position: Q2 2026 in Review
AssetMark Inc reduced its Chemours (CC) stake by 74% in Q2 2026, selling an estimated $12K and leaving 188 shares worth $3.86K. The position accounts for ﹤0.01% of the portfolio, ranked #2772.
AssetMark Inc first reported a position in CC in Q3 2015 and has held it in 32 quarters since. The position peaked at $50K in Q1 2019. 472 funds tracked by Wall St. Rank hold CC as of Q2 2026.
- AssetMark Inc held 188 shares of Chemours worth $3.86K as of Q2 2026.
- AssetMark Inc sold 522 Chemours shares in Q2 2026, an estimated $12K.
- Chemours made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2772 holding.
- AssetMark Inc first reported a position in Chemours in Q3 2015 and has held it in 32 quarters since.
- AssetMark Inc's Chemours position peaked at $50K in Q1 2019.
- 472 funds tracked by Wall St. Rank held Chemours as of Q2 2026.
Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.